Decreased prion protein expression in human peripheral blood leucocytes from patients with paroxysmal nocturnal

J Dürig1, A Giese, U Schmücker

  • 1Department of Haematology, University Hospital Essen, D-45122, Germany. duerig@t-online.de

Insights

This study reveals that patients with paroxysmal nocturnal haemoglobinuria (PNH) exhibit reduced cell surface prion protein (PrPC) expression on monocytes and granulocytes. Lymphocytes showed comparable PrPC levels, though some PNH patients had PrPC-deficient lymphocyte subpopulations.

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • The cellular prion protein (PrPC) is a GPI-anchored glycoprotein on the cell surface.
  • PrPC plays roles in cell activation, proliferation, and prion disease pathogenesis.
  • Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by deficiencies in GPI-linked proteins.

Purpose of the Study:

  • To investigate PrPC expression on peripheral blood cells from PNH patients.
  • To compare PrPC levels in PNH cells versus normal controls.
  • To identify potential alterations in PrPC expression patterns in PNH.

Main Methods:

  • Utilized the PrPC-specific monoclonal antibody (mAb) 3F4.
  • Employed flow cytometry to analyze PrPC surface expression.
  • Quantified PrPC levels using mean fluorescent intensity and histogram analysis.

Main Results:

  • PNH monocytes and granulocytes showed significantly lower PrPC surface immunoreactivity compared to normal controls.
  • PrPC was absent on PNH granulocytes.
  • Lymphocytes from most PNH patients displayed normal PrPC expression, but one patient had a PrPC-deficient lymphocyte subpopulation.

Conclusions:

  • PNH haemopoietic cells demonstrate a deficiency in cell surface-bound PrPC.
  • The findings highlight differential PrPC expression in PNH blood cell populations.
  • Further research may elucidate the functional implications of PrPC deficiency in PNH.